Improving lesion detection and visualization: implications for neurosurgical planning and follow-up (Q33292588)

25 July 2017

1 reference

title

Improving lesion detection and visualization: implications for neurosurgical planning and follow-up (English)

1 reference

25 July 2017

0 references

1 reference

Piero Picozzi

1

1 reference

25 July 2017

Miles A Kirchin

series ordinal

2

1 reference

25 July 2017

publication date

1 July 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

49 Suppl 1

1 reference

25 July 2017

page(s)

S27-34

1 reference

Long-term outcome of low-grade oligodendroglioma and mixed glioma.

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00234-007-1470-4

21 January 2018

Imaging in neurooncology

1 reference

https://api.crossref.org/works/10.1007/S00234-007-1470-4

The WHO classification of tumors of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00234-007-1470-4

Interscan variation in coronary artery calcium quantification in a large asymptomatic patient population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00234-007-1470-4

American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00234-007-1470-4

Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00234-007-1470-4

Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00234-007-1470-4

Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00234-007-1470-4

MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00234-007-1470-4

Increased detection of intracranial metastases with intravenous Gd-DTPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00234-007-1470-4

Presidential address: the histopathology of meningiomas. A reflection of origins and expected behavior?

21 January 2018

1 reference

12 December 2020

Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children

1 reference

12 December 2020

Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention

1 reference

12 December 2020

Postoperative imaging after brain tumor resection

1 reference

12 December 2020

Overview: Brain tumour diagnosis and management/Royal College of Physicians guidelines

1 reference

12 December 2020

Signs and symptoms of patients with brain tumors presenting to the emergency department

1 reference

12 December 2020

Early-postoperative magnetic resonance imaging in glial tumors: prediction of tumor regrowth and recurrence.

1 reference

12 December 2020

Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS

1 reference

12 December 2020

Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine

1 reference

12 December 2020

Immunohistochemical demonstration of serum proteins in human cerebral gliomas

1 reference

12 December 2020

Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: growth factor and Ras signaling pathways

1 reference

12 December 2020

1 reference

12 December 2020

Clinical applications of intracranial perfusion MR imaging.

1 reference

12 December 2020

Treatment of adults with recurrent malignant glioma

1 reference

12 December 2020

Therapeutic management of brain metastasis

1 reference

12 December 2020

Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium

1 reference

12 December 2020

Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system

1 reference

12 December 2020

Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.

1 reference

12 December 2020

A double-blind, comparative study of gadodiamide injection and gadopentetate dimeglumine in MRI of the central nervous system

1 reference

12 December 2020

Symptomatic management and imaging of brain metastases

1 reference

12 December 2020

Double-blind, efficacy evaluation of gadobenate dimeglumine, a gadolinium chelate with enhanced relaxivity, in malignant lesions of the brain

1 reference

12 December 2020

Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla

1 reference

12 December 2020

National survey of patterns of care for brain-tumor patients

1 reference

12 December 2020

Detection of intracranial metastases: a multicenter, intrapatient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dosage

1 reference

12 December 2020

Dose of contrast material in the MR imaging evaluation of central nervous system tumors

1 reference

12 December 2020

Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths

1 reference

12 December 2020

The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors

1 reference

12 December 2020

1 reference

12 December 2020

Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors.

1 reference

12 December 2020

Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents

1 reference

12 December 2020

Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging

1 reference

12 December 2020

Commonly used imaging techniques for diagnosis and staging.

1 reference

12 December 2020

Brain tumours: incidence, survival, and aetiology

1 reference

12 December 2020

Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance

1 reference

12 December 2020

Brain tumor survival: results from the National Cancer Data Base

1 reference

12 December 2020

Intraoperative magnetic resonance imaging and magnetic resonance imaging-guided therapy for brain tumors

1 reference

12 December 2020

Viral therapy for glioblastoma

1 reference

12 December 2020

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials

1 reference

12 December 2020

An overview of principles for classifying brain tumors

1 reference

12 December 2020

Current treatment paradigms for the management of patients with brain metastases

1 reference

12 December 2020

Central nervous system: review of clinical use of contrast media

1 reference

12 December 2020

Perfusion MR imaging of brain neoplasms

1 reference

12 December 2020

Meningiomas and arachnoid cells: an immunohistochemical study of epithelial markers

1 reference

12 December 2020

Advances in magnetic resonance imaging of brain tumours

1 reference

12 December 2020

Chemotherapy for adults with malignant glioma

1 reference

12 December 2020

Gadobenate dimeglumine-enhanced magnetic resonance imaging of intracranial metastases: effect of dose on lesion detection and delineation

1 reference

12 December 2020

The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial

1 reference

12 December 2020

Phase III, randomized, double-blind, cross-over comparison of gadoteridol and gadopentetate dimeglumine in magnetic resonance imaging of patients with intracranial lesions

1 reference

12 December 2020

Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging

1 reference

12 December 2020

The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis

1 reference

12 December 2020

A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumours

1 reference

12 December 2020

Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA.

1 reference

12 December 2020

Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.

1 reference

12 December 2020

Contrast dosage in the neuroimaging of brain tumors. Principles and indications

1 reference

12 December 2020

Advances in gene therapy and immunotherapy for brain tumors

1 reference

12 December 2020

Intraindividual comparison of gadobenate dimeglumine and gadobutrol for cerebral magnetic resonance perfusion imaging at 1.5 T.

1 reference

12 December 2020

Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases

1 reference

12 December 2020

The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data

1 reference

12 December 2020

Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991

1 reference

12 December 2020

Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001.

1 reference

12 December 2020

Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis

1 reference

12 December 2020

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project

1 reference

12 December 2020

Intraoperative high-field-strength MR imaging: implementation and experience in 200 patients

1 reference

12 December 2020

Evaluation of subsecond gated helical CT for quantification of coronary artery calcium and comparison with electron beam CT

1 reference

12 December 2020

Aggressive surgery for malignant supratentorial gliomas.

1 reference

12 December 2020

10.1007/S00234-007-1470-4

Identifiers

DOI

1 reference

Dimensions Publication ID

25 July 2017

1004639680

0 references

1 reference